News

Researchers at the University of Cincinnati have developed a new method of delivering radiation therapy to cancer cells – using engineered bacteria.

Many studies are looking for ways to optimize absorption of bioactive compounds by the organism and increase their bioavailability – the proportion that enters the bloodstream after absorption. One way is to coat the compounds with another material and package them on the nanometric scale (a nanometer is a billionth of a meter).

A novel chemical-creation platform is being unearthed that could help breathe new life into tired drugs and agrochemicals.

Patients with advanced endometrial cancer saw a significant reduction in disease growth with the combination immunotherapy and chemotherapy.

New research has indicated that our microbiomes may harbor antibiotic-resistance genes, particularly in countries with a heavy burden of antibiotic consumption.

A new drug combination against advanced prostate cancer has shown promise in a new phase 3 trial, increasing 5-year survival rates to 67%.

HIV can persist in a subset of white blood cells even if the patient is taking antiretroviral therapy, reports a new study.

A protein family’s role in the regulation of fast-twitch muscle fibers – those involved in fast and powerful movements – has been identified by scientists at the University of Tsukuba. The research is published in Cell Reports.

New research finds that select patients with early-stage non-small cell lung cancer who undergo a less invasive procedure have comparable outcomes to those who receive a lobectomy.

Researchers have created a way to synthesize a molecule with remarkable anticancer properties, jerantinine A, produced by a plant called Tabernaemontana corymbosa.